Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > I thought…
View:
Post by mercedesman on Apr 10, 2023 9:48am

I thought…

I thought JK did an excellent job of explaining why enrolment will increase in clinical practice and once the SOC versus under the strict Trial criteria 

Which also helps to explain the underestimated EBITDA calculations and the true addressable market (300,000 to 400,000) or 2 to 3 times more than the number of patients assumed (140,000) in the EBITDA calculations. 

That plus the guided and comparable EBITDA multiples mentioned during the presentation , mean that a new SP valuation/ calculation will soon be in order  ! 

Also good to see that JK is committed to seeing this through and sees it the culmination of his life's work in Sepsis and hemoperfusion.

Excited to see what transpires in the next 12-24 months !!

Holding and strategically still accumulating based on explosive potential. 

MM
Comment by hmmmmmmmm on Apr 10, 2023 3:06pm
The problem is, Kellum told us all on multiple occasions about how flu season was going to increase Tigris enrollment. On multiplce occasions he told us the start date for the DIMI trial.. They talked about DIMI and SAMI as "disruptive technology" only to 180 on that. His "Worst Case" enrollment numbers?  Dead wrong. How many times can he be wrong on the company's ...more  
Comment by mercedesman on Apr 10, 2023 4:25pm
Hmmmmm when you have achieved a 30 year career studying Sepsis ( other than buying Spectral shares) and decide to leave your professorship position at a major US University, and have run several Trials on one of the most complex human conditions to try to resolve with a RCT,  and are considered a Key Opinion Leader on the topic of Sepsis and blood perfusion world-wide ... THEN  I will ...more  
Comment by Accountprince on Apr 10, 2023 5:47pm
Unfortunately I was not able to attend the presentation last Thursday due to holiday family commitments.  I have just read the presentation and my take is as follows: If you're an optimist you will accept everything that management has said. If you're a pessimist you'll reject everything that management has said. If you're a pragmatist you realize that this management team ...more  
Comment by Revten on Apr 10, 2023 3:16pm
MM I am in complete agreement with you on this post! I too will HOLD without question and based on the New Projections will only see my investment potential grow by several million dollars even on the conservative side! 12 to 24 months for that kind of an additional return is a No Brainer! And I will continue to Accumulate regardless! Still REVED UP!
Comment by mercedesman on Apr 10, 2023 4:33pm
Yes I agree Rev ! the upside potential has been made much more clear with this presentation  the commitment from Baxter and Kellum is also crystal clear.  the explanations for past delays make sense. New go-forward strategies given difficult post-pandemic conditions also make sense. Feeling much better about my investment.  Some Profits from my considerable precious ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities